Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 119.50
-0.50 (-0.42%)
At close: Mar 13, 2026
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 17.7 billion as of March 13, 2026. Its market cap has decreased by -19.80% in one year.
Market Cap
17.70B
Enterprise Value
15.36B
Revenue
10.25B
Ranking
n/a
PE Ratio
14.63
Stock Price
119.50
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 17.70B, an increase of 662.20%. That is a compound annual growth rate of 6.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 17.70B | -5.53% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 33.15B |
| TTY Biopharm Company | 20.49B |
| ScinoPharm Taiwan | 17.00B |
| Synmosa Biopharma | 15.67B |
| YungShin Global Holding | 14.22B |
| Alar Pharmaceuticals | 12.96B |
| Foresee Pharmaceuticals | 12.78B |
| Handa Pharmaceuticals | 12.26B |